<SEC-DOCUMENT>0001193125-20-241611.txt : 20200909
<SEC-HEADER>0001193125-20-241611.hdr.sgml : 20200909
<ACCEPTANCE-DATETIME>20200909080205
ACCESSION NUMBER:		0001193125-20-241611
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		14
CONFORMED PERIOD OF REPORT:	20200903
ITEM INFORMATION:		Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20200909
DATE AS OF CHANGE:		20200909

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			UroGen Pharma Ltd.
		CENTRAL INDEX KEY:			0001668243
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			L3
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-38079
		FILM NUMBER:		201165481

	BUSINESS ADDRESS:	
		STREET 1:		9 HA'TA'ASIYA ST
		CITY:			RA'ANANA
		STATE:			L3
		ZIP:			4365007
		BUSINESS PHONE:		972 9 770 7601

	MAIL ADDRESS:	
		STREET 1:		9 HA'TA'ASIYA ST
		CITY:			RA'ANANA
		STATE:			L3
		ZIP:			4365007
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>d19897d8k.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8" ?>
<html xmlns:dei="http://xbrl.sec.gov/dei/2019-01-31" xmlns:us-types="http://fasb.org/us-types/2019-01-31" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:urgn="http://www.urogen.com/20200903" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:sic="http://xbrl.sec.gov/sic/2011-01-31" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns="http://www.w3.org/1999/xhtml">
<head>
<title>8-K</title>
<meta http-equiv="Content-Type" content="text/html" />
</head>
   <body>
 <div style="display:none"> <ix:header> <ix:hidden> <ix:nonNumeric name="dei:AmendmentFlag" contextRef="duration_2020-09-03_to_2020-09-03">false</ix:nonNumeric> <ix:nonNumeric id="Hidden_dei_EntityCentralIndexKey" name="dei:EntityCentralIndexKey" contextRef="duration_2020-09-03_to_2020-09-03">0001668243</ix:nonNumeric> </ix:hidden> <ix:references> <link:schemaRef xlink:type="simple" xlink:href="urgn-20200903.xsd" xlink:arcrole="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase"></link:schemaRef> </ix:references> <ix:resources> <xbrli:context id="duration_2020-09-03_to_2020-09-03"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001668243</xbrli:identifier> </xbrli:entity> <xbrli:period> <xbrli:startDate>2020-09-03</xbrli:startDate> <xbrli:endDate>2020-09-03</xbrli:endDate> </xbrli:period> </xbrli:context> </ix:resources> </ix:header> </div> <div style="text-align:center"> <div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto"> <p style="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&#160;</p> <p style="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&#160;</p> <p style="margin-top:4pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman;font-weight:bold;text-align:center">UNITED STATES</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman;font-weight:bold;text-align:center">SECURITIES AND EXCHANGE COMMISSION</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">Washington, D.C. 20549</p> <p style="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="margin-top:10pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman;font-weight:bold;text-align:center">FORM <ix:nonNumeric name="dei:DocumentType" contextRef="duration_2020-09-03_to_2020-09-03">8-K</ix:nonNumeric></p> <p style="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="margin-top:10pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">CURRENT REPORT</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">Pursuant to Section 13 or 15(d)</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">of the Securities Exchange Act of 1934</p> <p style="margin-top:10pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">Date of Report (Date of earliest event reported): <ix:nonNumeric name="dei:DocumentPeriodEndDate" contextRef="duration_2020-09-03_to_2020-09-03" format="ixt:datemonthdayyearen">September 3, 2020</ix:nonNumeric></p> <p style="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="margin-top:10pt; margin-bottom:0pt; font-size:24pt; font-family:Times New Roman;font-weight:bold;text-align:center"> <ix:nonNumeric name="dei:EntityRegistrantName" contextRef="duration_2020-09-03_to_2020-09-03">UROGEN PHARMA LTD.</ix:nonNumeric> </p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Exact name of registrant as specified in its charter)</p> <p style="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="border-collapse:collapse; font-family:Times New Roman; font-size:8pt;width:100%;border:0;margin:0 auto">
<tr>
<td style="width:34%"></td>
<td style="vertical-align:bottom"></td>
<td style="width:32%"></td>
<td style="vertical-align:bottom;width:1%"></td>
<td style="width:32%"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><ix:nonNumeric name="dei:EntityIncorporationStateCountryCode" contextRef="duration_2020-09-03_to_2020-09-03" format="ixt-sec:edgarprovcountryen">Israel</ix:nonNumeric></span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><ix:nonNumeric name="dei:EntityFileNumber" contextRef="duration_2020-09-03_to_2020-09-03">001-38079</ix:nonNumeric></span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><ix:nonNumeric name="dei:EntityTaxIdentificationNumber" contextRef="duration_2020-09-03_to_2020-09-03">98-1460746</ix:nonNumeric></span></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style=" text-align: center;margin:auto; vertical-align:top"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(State or other jurisdiction</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">of incorporation)</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Commission</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">File Number)</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(IRS Employer</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Identification No.)</p></td></tr></table> <p style="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;width:100%;border:0;margin:0 auto">
<tr>
<td style="width:50%"></td>
<td style="vertical-align:bottom;width:1%"></td>
<td style="width:48%"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style=" text-align: center;margin:auto; vertical-align:top"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center"><ix:nonNumeric name="dei:EntityAddressAddressLine1" contextRef="duration_2020-09-03_to_2020-09-03">400 Alexander Park Drive</ix:nonNumeric>, <ix:nonNumeric name="dei:EntityAddressAddressLine2" contextRef="duration_2020-09-03_to_2020-09-03">4<sup style="font-size:85%; vertical-align:top">th</sup> Floor</ix:nonNumeric></p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center"><ix:nonNumeric name="dei:EntityAddressCityOrTown" contextRef="duration_2020-09-03_to_2020-09-03">Princeton</ix:nonNumeric>, <ix:nonNumeric name="dei:EntityAddressStateOrProvince" contextRef="duration_2020-09-03_to_2020-09-03" format="ixt-sec:stateprovnameen">New Jersey</ix:nonNumeric></p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:bottom"><span style="font-weight:bold"><ix:nonNumeric name="dei:EntityAddressPostalZipCode" contextRef="duration_2020-09-03_to_2020-09-03">08540</ix:nonNumeric></span></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold">(Address of principal executive offices)</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold">(Zip Code)</span></td></tr></table> <p style="margin-top:10pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">Registrant&#8217;s telephone number, including area code: <ix:nonNumeric name="dei:CityAreaCode" contextRef="duration_2020-09-03_to_2020-09-03">+1 (646)</ix:nonNumeric> <ix:nonNumeric name="dei:LocalPhoneNumber" contextRef="duration_2020-09-03_to_2020-09-03">768-9780</ix:nonNumeric></p> <p style="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="margin-top:10pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Check the appropriate box below if the Form <span style="white-space:nowrap">8-K</span> filing is intended to simultaneously satisfy the filing obligations of the registrant under any of the following provisions:</p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top"><ix:nonNumeric name="dei:WrittenCommunications" contextRef="duration_2020-09-03_to_2020-09-03" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top"><ix:nonNumeric name="dei:SolicitingMaterial" contextRef="duration_2020-09-03_to_2020-09-03" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Soliciting material pursuant to Rule <span style="white-space:nowrap">14a-12</span> under the Exchange Act (17 CFR <span style="white-space:nowrap">240.14a-12)</span></p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top"><ix:nonNumeric name="dei:PreCommencementTenderOffer" contextRef="duration_2020-09-03_to_2020-09-03" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="white-space:nowrap">Pre-commencement</span> communications pursuant to Rule <span style="white-space:nowrap">14d-2(b)</span> under the Exchange Act (17 CFR <span style="white-space:nowrap">240.14d-2(b))</span></p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top"><ix:nonNumeric name="dei:PreCommencementIssuerTenderOffer" contextRef="duration_2020-09-03_to_2020-09-03" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="white-space:nowrap">Pre-commencement</span> communications pursuant to Rule <span style="white-space:nowrap">13e-4(c)</span> under the Exchange Act (17 CFR <span style="white-space:nowrap">240.13e-4(c))</span></p></td></tr></table> <p style="margin-top:10pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Securities registered pursuant to Section 12(b) of the Act:</p> <p style="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="border-collapse:collapse; font-family:Times New Roman; font-size:8pt;width:100%;border:0;margin:0 auto">
<tr>
<td style="width:34%"></td>
<td style="vertical-align:bottom"></td>
<td style="width:32%"></td>
<td style="vertical-align:bottom;width:1%"></td>
<td style="width:32%"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style=" text-align: center;margin:auto; border-bottom:1.00pt solid #000000;vertical-align:bottom;white-space:nowrap"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Title of each class</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; border-bottom:1.00pt solid #000000;vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Trading</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Symbol(s)</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; border-bottom:1.00pt solid #000000;vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Name of each exchange</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">on which registered</p></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style=" text-align: center;margin:auto; vertical-align:top"> <ix:nonNumeric name="dei:Security12bTitle" contextRef="duration_2020-09-03_to_2020-09-03"><p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">Ordinary Shares,</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">par value NIS0.01 per share</p></ix:nonNumeric></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><ix:nonNumeric name="dei:TradingSymbol" contextRef="duration_2020-09-03_to_2020-09-03">URGN</ix:nonNumeric></span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><ix:nonNumeric name="dei:SecurityExchangeName" contextRef="duration_2020-09-03_to_2020-09-03" format="ixt-sec:exchnameen">The Nasdaq Stock Market LLC</ix:nonNumeric></span></td></tr></table> <p style="margin-top:10pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405 of this chapter) or Rule <span style="white-space:nowrap">12b-2</span> of the Securities Exchange Act of 1934 <span style="white-space:nowrap">(&#167;240.12b-2</span> of this chapter).</p> <p style="margin-top:10pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Emerging growth company&#160;&#160;<ix:nonNumeric name="dei:EntityEmergingGrowthCompany" contextRef="duration_2020-09-03_to_2020-09-03" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></p> <p style="margin-top:10pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section&#160;13(a) of the Exchange Act.&#160;&#160;&#9744;</p> <p style="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <p style="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&#160;</p> <p style="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&#160;</p></div></div>

<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">

<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:11%;vertical-align:top" align="left"><span style="font-weight:bold">Item&#160;5.02</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:left">Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. </p></td></tr></table> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">(b) Departure of Peter Pfreundschuh as Chief Financial Officer </span></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On September&#160;8, 2020, UroGen Pharma Ltd. (the &#8220;Company&#8221;), entered into a Separation Agreement with Peter Pfreundschuh (the &#8220;Separation Agreement&#8221;), the Company&#8217;s Chief Financial Officer, which sets forth the terms of Mr.&#160;Pfreundschuh&#8217;s termination of employment with the Company, effective as of October&#160;15, 2020 (the &#8220;Separation Date&#8221;). Pursuant to the terms of the Separation Agreement, and in exchange for Mr.&#160;Pfreundschuh providing the Company with an effective release of claims and agreeing to refrain from certain conduct, the Company agreed to provide Mr.&#160;Pfreundschuh with (1)&#160;cash severance equivalent to six months of Mr.&#160;Pfreundschuh&#8217;s base salary in effect as of the Separation Date, (2)&#160;the equivalent of nine months of Mr.&#160;Pfreundschuh&#8217;s pro rata portion of his current potential annual 50% target bonus for calendar year 2020, which shall be awarded only to the extent earned based on actual Company performance, with any individual performance component deemed achieved, to be paid on the date in the year following Mr.&#160;Pfreundschuh&#8217;s termination on which bonuses are paid to other senior executives of the Company, but in no event later than March&#160;15 of such year, (3)&#160;the accelerated vesting of each restricted stock unit and option held by Mr.&#160;Pfreundschuh, such that the amount of each award that would have otherwise become vested as of April&#160;15, 2021, shall become issuable or exercisable, respectively, as of the Separation Date, and the date to exercise such options shall be increased to 180 days post the Separation Date, and (4)&#160;certain health insurance coverage starting on the Separation Date. The forgoing description of the Separation Agreement is not complete and is qualified in its entirety by reference to the full text of the Separation Agreement, a copy of which is filed as Exhibit 10.1 to this Current Report on Form <span style="white-space:nowrap">8-K.</span> </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">(c) Appointment of Molly Henderson as Chief Financial Officer </span></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Effective as of October&#160;1, 2020 (the &#8220;Start Date&#8221;), the Company appointed Molly Henderson as Chief Financial Officer of the Company, as well as the Company&#8217;s principal financial officer and principal accounting officer, replacing Mr.&#160;Pfreundschuh in such roles. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Prior to joining the Company, Ms.&#160;Henderson served as Executive Vice President, Corporate Secretary and Chief Financial Officer of Advaxis, Inc., a clinical-stage biotechnology company focused on the development and commercialization of immunotherapy products, from June 2018 to September 2020. Prior to Advaxis, Ms.&#160;Henderson was a freelance consultant, as well as the Chairman and partial owner of WUJU Foods, LLC, a consumer products company, from August 2016 to June 2018. Prior to that, Ms.&#160;Henderson was Chief Financial Officer at Iovance Biotherapeutics, Inc. (formerly Lion Biotechnologies, Inc.) from June 2015 to August 2016. Ms.&#160;Henderson also served as the Chief Business and Financial Officer, Senior Vice President of VirtualScopics, Inc., a public company provider of imaging solutions to the pharmaceutical, biotechnology, and medical device industries, from May 2008 to August 2013, and as that company&#8217;s Chief Financial Officer from May 2003 to May 2008. From 2013 to 2015, Ms.&#160;Henderson relocated her family to Europe, during which time Ms.&#160;Henderson advised <span style="white-space:nowrap">start-up</span> companies in Switzerland. Earlier in her career, Ms.&#160;Henderson served as the Corporate Controller of Ultralife, Inc., a publicly-held provider of high performance lithium battery solutions. Prior to Ultralife, Ms.&#160;Henderson was a Manager in the audit division of PricewaterhouseCoopers LLP. Ms.&#160;Henderson received her M.B.A. and B.S. degrees from the State University of New York at Buffalo. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company and Ms.&#160;Henderson entered into an Employment Agreement on September&#160;3, 2020 (the &#8220;Employment Agreement&#8221;). Pursuant to the terms of the Employment Agreement, Ms.&#160;Henderson is entitled to an initial annualized base salary of $430,000. Ms.&#160;Henderson will also be entitled to a <span style="white-space:nowrap">one-time</span> signing bonus of $100,000, subject to repayment by Ms.&#160;Henderson if she resigns without good reason or the Company terminates her employment for cause prior to the <span style="white-space:nowrap">one-year</span> anniversary of the Start Date, and an annual discretionary cash bonus of up to 50% of Ms.&#160;Henderson&#8217;s then-current base salary, <span style="white-space:nowrap">pro-rated</span> in the case of a partial calendar year. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Employment Agreement also provides that, subject to approval by the Board of Directors of the Company (the &#8220;Board&#8221;) (or a committee thereof), and as an inducement material to Ms.&#160;Henderson entering into employment with the Company, pursuant to Nasdaq Rule 5635(c)(4), Ms.&#160;Henderson shall be granted (i)&#160;a stock option to purchase 60,000 of the Company&#8217;s ordinary shares, par value NIS 0.01, with an exercise price per share equal to the closing price per share on the grant date (the &#8220;Initial Option&#8221;) and (ii) 15,000 restricted stock units of the Company (the </p>
</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
&#8220;RSU&#8221;). The shares subject to the Initial Option and RSU will each vest over three years of continuous service by Ms.&#160;Henderson to the Company, with 1/3 of the shares vesting upon Ms.&#160;Henderson&#8217;s completion of one year of service measured from the Start Date and 1/3 of the shares annually thereafter for the remaining two years. The Initial Option and RSU will be granted under the Company&#8217;s Inducement Plan, and Ms.&#160;Henderson will be eligible for future equity awards under the Company&#8217;s 2017 Equity Incentive Plan, as amended, as approved by the Board (or a committee thereof) in its sole discretion. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Under the terms of the Employment Agreement, if Ms.&#160;Henderson is terminated by the Company without cause or resigns for good reason, she is entitled to receive (i)&#160;payment of her then-current base salary through the effective date of the termination or resignation, (ii)&#160;continuation of Ms.&#160;Henderson&#8217;s salary at the rate in effect at the time of termination for a period of six months following the termination date, (iii)&#160;a <span style="white-space:nowrap">pro-rata</span> bonus through the date of termination, which bonus shall be paid only to the extent earned based on actual Company performance, not to exceed 100% of the target (with any individual performance component deemed achieved), on the date in the year following termination on which bonuses are paid to other senior executives of the Company (but in any event prior to March 15<sup style="font-size:85%; vertical-align:top">th</sup> of such year), (iv) any annual bonus earned with respect to the year preceding the year of termination, if not already paid by the date of termination, (v)&#160;accelerated vesting of any of Ms.&#160;Henderson&#8217;s unvested equity awards, including the Initial Option and RSU, such that shares that would have vested over an additional quarter following the termination date shall be deemed immediately vested and exercisable as of Ms.&#160;Henderson&#8217;s last day of employment, and (vi)&#160;reimbursement of COBRA healthcare premium costs for the same level of coverage she had during employment for up to six months or until the date Ms.&#160;Henderson becomes eligible for new healthcare coverage through another source. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In addition to the foregoing, in connection with an acquisition of the Company where Ms.&#160;Henderson&#8217;s employment is terminated without cause, or she resigns for good reason, in either case within three months prior to, or 24 months following the close of such acquisition, Ms.&#160;Henderson shall be entitled to the following benefits: (A)&#160;a lump sum payment equal to the sum of (y) 12 months of her then-current annual base salary and (z) 100% of the current target bonus percentage of her current annual base salary; (B)&#160;the amount of any COBRA continuation premium payments made by Ms.&#160;Henderson during the 12 month period following the date of termination, or the period ending when Ms.&#160;Henderson becomes eligible for comparable group medical benefits from another source (whichever comes first); and (C)&#160;the vesting of the Initial Option and RSU, as well as any other equity awards granted to Ms.&#160;Henderson, shall be accelerated in full such that 100% of the then-unvested shares subject to the Initial Option and RSU (or other equity awards) will be deemed vested and exercisable as of Ms.&#160;Henderson&#8217;s last day of employment. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The severance benefits described in the foregoing paragraph are, in each case, subject to Ms.&#160;Henderson&#8217;s compliance with continuing obligations to the Company and her execution of a separation agreement and general release in favor of the Company. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Ms.&#160;Henderson has no family relationships with any of the Company&#8217;s directors or executive officers, and she has no direct or indirect material interest in any transaction required to be disclosed pursuant to Item 404(a) of Regulation <span style="white-space:nowrap">S-K.</span> </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The foregoing description of the Employment Agreement is not complete and is qualified in its entirety by reference to the full text of the Employment Agreement, a copy of which is filed as Exhibit 10.2 to this Current Report on Form <span style="white-space:nowrap">8-K.</span> </p> <p style="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:10%;vertical-align:top" align="left"><span style="font-weight:bold">Item&#160;9.01</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:left">Financial Statements and Exhibits. </p></td></tr></table> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(d) </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:100%;border:0;margin:0 auto">


<tr>

<td></td>

<td style="vertical-align:bottom;width:5%"></td>
<td style="width:92%"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom;white-space:nowrap" align="center"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Exhibit</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Number</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap" align="center"><span style="font-weight:bold">Description</span></td></tr>


<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">10.1*</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="d19897dex101.htm">Separation Agreement between the Company and Peter Pfreundschuh, dated September&#160;8, 2020. </a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">10.2</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="d19897dex102.htm">Employment Agreement between the Company and Molly Henderson, dated September&#160;3, 2020. </a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">104</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top">Cover Page Interactive Data File (embedded within the Inline XBRL document).</td></tr>
</table> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:2%;vertical-align:top" align="left">*</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Schedules have been omitted pursuant to Item 601(a)(5) of Regulation <span style="white-space:nowrap">S-K.</span> A copy of any omitted schedules will be furnished to the SEC upon request. </p></td></tr></table>
</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">SIGNATURES </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:100%;border:0">


<tr>

<td style="width:45%"></td>

<td style="vertical-align:bottom;width:1%"></td>
<td style="width:4%"></td>

<td style="vertical-align:bottom"></td>
<td style="width:3%"></td>

<td style="vertical-align:bottom;width:1%"></td>
<td style="width:45%"></td></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top">Date: September&#160;9, 2020</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top" colspan="3"><span style="font-weight:bold">UROGEN PHARMA LTD.</span></td></tr>
<tr style="font-size:1pt">
<td style="height:12pt"></td>
<td style="height:12pt" colspan="2"></td>
<td style="height:12pt" colspan="2"></td>
<td style="height:12pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top">By:</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top"> <p style="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Elizabeth Barrett</p></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top">Elizabeth Barrett</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top">Chief Executive Officer</td></tr>
</table>
</div></div>

</body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.1
<SEQUENCE>2
<FILENAME>d19897dex101.htm
<DESCRIPTION>EX-10.1
<TEXT>
<HTML><HEAD>
<TITLE>EX-10.1</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 10.1 </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">September&nbsp;8, 2020 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Peter Pfreundschuh </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Dear Peter: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This letter sets forth the
substance of the separation agreement (the &#147;<B>Agreement</B>&#148;) that UroGen Pharma, Inc. (the &#147;<B>Company</B>&#148;) is offering to you to aid in your employment transition, and in accordance with the Executive Employment Agreement
between the Company and you, dated July&nbsp;31, 2018 (the &#147;<B>Employment Agreement</B>&#148;). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>1.</B>&nbsp;&nbsp;&nbsp;&nbsp;<B>S<SMALL>EPARATION</SMALL></B><SMALL><B></B></SMALL><B>.</B> Your employment termination date will be
October&nbsp;15, 2020 (the &#147;<B>Separation Date</B>&#148;). As of the Separation Date, you will also be deemed to have resigned from any other position or office you hold with the Company, UroGen Pharma, Ltd. (&#147;<B>Parent</B>&#148;), and any
of their affiliates. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>2.</B>&nbsp;&nbsp;&nbsp;&nbsp;<B>A<SMALL>CCRUED</SMALL> S<SMALL>ALARY</SMALL> <SMALL>AND</SMALL>
P<SMALL>AID</SMALL> T<SMALL>IME</SMALL> O<SMALL>FF</SMALL></B><SMALL><B></B></SMALL><B>.</B> On the next payroll date after the Separation Date, the Company will pay you all accrued salary, and all accrued and unused paid time off earned through the
Separation Date, subject to standard payroll deductions and withholdings. You are entitled to these payments regardless of whether or not you sign this Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>3.</B>&nbsp;&nbsp;&nbsp;&nbsp;<B>S<SMALL>EVERANCE</SMALL> B<SMALL>ENEFITS</SMALL></B><SMALL><B></B></SMALL><B>. </B>Although the Company
has no obligation to do so, if you: (i)&nbsp;sign and return this Agreement to the Company on or within <FONT STYLE="white-space:nowrap">twenty-one</FONT> (21)&nbsp;days after the Separation Date; (ii)&nbsp;allow the releases contained herein to
become effective; (iii)&nbsp;remain reasonably available after your Separation Date to answer any questions from the Company regarding your previous job duties; and (iv)&nbsp;comply with this Agreement and all of your legal and contractual
obligations to the Company, then the Company will provide you with the following severance benefits (the &#147;<B>Severance Benefits</B>&#148;): </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:7%; font-size:10pt; font-family:Times New Roman"><B>(a)</B>&nbsp;&nbsp;&nbsp;&nbsp;<B>Severance Payment. </B>The Company will pay you, as severance, an amount equivalent to six
(6)&nbsp;months of your current base salary (in the gross amount of $224,347), subject to standard payroll deductions and withholdings (the &#147;<B>Severance Payment</B>&#148;). The Severance Payment will be paid to you as a continuation on the
Company&#146;s regular payroll, beginning within ten (10)&nbsp;days after the Effective Date (as defined below). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:7%; font-size:10pt; font-family:Times New Roman"><B>(b)</B>&nbsp;&nbsp;&nbsp;&nbsp;<B><FONT STYLE="white-space:nowrap">Pro-Rata</FONT> Bonus</B>. You will be eligible to receive the
equivalent of a nine (9)&nbsp;month pro rata portion of your current potential annual 50% target bonus for calendar year 2020 (the &#147;<B>Pro Rata Bonus</B>&#148;). The Pro Rata Bonus shall be paid only to the extent earned based on actual Company
performance, with any individual performance component deemed achieved (for example, if the Company&#146;s corporate goals for 2020 are deemed achieved at the 110% level, your Pro Rata Bonus will be $185,086.27 (1.1*9/12*.5*$448,694)). The Pro Rata
Bonus will be paid to you, subject to standard payroll deductions and withholdings, on the date in the year following your termination on which bonuses are paid to other senior executives of the Company, but in no event later than March&nbsp;15 of
such year. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Peter Pfreundschuh </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"> Page
 2
 </P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:7%; font-size:10pt; font-family:Times New Roman"><B>(c) </B>&nbsp;&nbsp;&nbsp;&nbsp;<B>Equity Acceleration</B>. As summarized in <B>Exhibit
A</B> to this Agreement, you were previously granted a total of 23,500 shares of restricted stock of Parent (collectively, the &#147;<B>RS</B>&#148;) and options to purchase a total of 80,000 ordinary shares of the Parent (collectively, the
&#147;<B>Option</B>&#148;). Under the terms of the governing plan documents and Option and RS agreements, all vesting will cease as of the Separation Date. As an additional Severance Benefit, the vesting of each RS and Option grant shall accelerate
such that the amount of each RS and Option that would have otherwise become vested as of April&nbsp;15, 2021, shall become issuable or exercisable, respectively, as of the Separation Date. The vested amounts of each such RS and Option grant are set
forth in <B>Exhibit A</B>, which you acknowledge and agree correctly sets forth all of your equity interests in the Company, Parent, or any affiliate. Also as an additional Severance Benefit, the post termination exercise period for your vested
Options as of the Separation Date shall be extended to 180 days following the Separation Date. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:7%; font-size:10pt; font-family:Times New Roman"><B>(d)</B>&nbsp;&nbsp;&nbsp;&nbsp;<B>Health Insurance. </B>To the extent provided by the federal COBRA law or, if applicable, state insurance
laws, and by the Company&#146;s current group health insurance policies, you will be eligible to continue your group health insurance benefits at your own expense. Later, you may be able to convert to an individual policy through the provider of the
Company&#146;s health insurance, if you wish. If you timely elect continued coverage under COBRA, the Company will pay for the COBRA premiums to continue your health insurance coverage (including coverage for eligible dependents, if applicable)
(&#147;<B>COBRA Premiums</B>&#148;) through the period (the &#147;<B>COBRA Premium Period</B>&#148;) starting on the Separation Date and ending on the earliest to occur of: (i)&nbsp;the six (6)&nbsp;month anniversary of the Separation Date;
(ii)&nbsp;the date you become eligible for group health insurance coverage through a new employer; or (iii)&nbsp;the date you cease to be eligible for COBRA continuation coverage for any reason. You must timely pay your premiums, and then provide
the Company with proof of same to obtain reimbursement for your COBRA premiums under this Section&nbsp;3(d). In the event you become covered under another employer&#146;s group health plan or otherwise cease to be eligible for COBRA during the COBRA
Premium Period, you must immediately notify the Company of such event. Notwithstanding the foregoing, if the Company determines, in its sole discretion, that it cannot pay the COBRA Premiums without a substantial risk of violating applicable law
(including, without limitation, Section&nbsp;2716 of the Public Health Service Act), the Company instead shall pay you, on the first day of each calendar month, a fully taxable cash payment equal to the applicable COBRA premiums for that month for
the remainder of the COBRA Premium Period, which you may (but are not obligated to) use toward the cost of COBRA premiums. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>4.</B>&nbsp;&nbsp;&nbsp;&nbsp;<B>O<SMALL>THER</SMALL> C<SMALL>OMPENSATION</SMALL> <SMALL>OR</SMALL> B<SMALL>ENEFITS</SMALL>.</B> You
acknowledge and agree that the Severance Benefits represent full and complete satisfaction of the benefits you may be eligible to receive pursuant to the Employment Agreement, any prior employment agreement or offer letter, or otherwise. You
acknowledge that, except for your base salary and as expressly provided in this Agreement, you have not earned and will not receive from the Company any additional compensation (including bonus, incentive compensation, or equity), severance, or
benefits before or after the Separation Date, with the exception of any vested right you may have under the express terms of a written ERISA-qualified benefit plan (e.g., 401(k) account). </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Peter Pfreundschuh </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"> Page
 3
 </P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>5.</B>&nbsp;&nbsp;&nbsp;&nbsp;<B>E<SMALL>XPENSE</SMALL> R<SMALL>EIMBURSEMENTS</SMALL>.</B>
You agree that, within thirty (30)&nbsp;days after the Separation Date, you will submit your final documented expense reimbursement statement reflecting all business expenses you incurred through the Separation Date, if any, for which you seek
reimbursement. The Company will reimburse you for these expenses pursuant to its regular business practice. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>6.&nbsp;&nbsp;&nbsp;&nbsp;R<SMALL>ETURN</SMALL> <SMALL>OF</SMALL> C<SMALL>OMPANY</SMALL> P<SMALL>ROPERTY</SMALL>.</B> On or within five
(5)&nbsp;days after the Separation Date, you will return to the Company all Company documents (and all copies thereof) and other Company property in your possession or control, including, but not limited to, Company files, notes, drawings, records,
business plans and forecasts, contact information, financial information, specifications, training materials, computer-recorded information, tangible property including, but not limited to, computers, credit cards, entry cards, identification badges
and keys; and any materials of any kind that contain or embody any proprietary or confidential information of the Company (and all reproductions thereof). You represent that you have made a diligent search to locate any such documents, property and
information within the required timeframe. In addition, if you have used any personally owned computer, server, <FONT STYLE="white-space:nowrap">e-mail</FONT> system, mobile phone, portable electronic device (e.g., smartphone, iPad or the like),
(collectively, &#147;<B>Personal Systems</B>&#148;) to receive, store, prepare or transmit any Company confidential or proprietary data, materials or information, then within five (5)&nbsp;days after the Separation Date, you will permanently delete
and expunge all such Company confidential or proprietary information from such Personal Systems without retaining any copy or reproduction in any form (in whole or in part). The Company shall permit you to transfer from your work computer to a
personal storage mechanism prior to the Separation Date your personal email folder, personal photos, music and video files, personal electronic files, and personal contact and calendar database, subject to reasonable review and approval of such
transfers by the Company. <B>You agree that, after the applicable timeframes noted above, you will neither use nor possess Company property. Your timely compliance with this paragraph is a condition precedent to your receipt of the Severance
Benefits described above.</B> </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>7.</B>&nbsp;&nbsp;&nbsp;&nbsp;<B>C<SMALL>ONFIDENTIALITY</SMALL>.</B> Notwithstanding any provision in
this Agreement or the Confidentiality Agreement (defined below) to the contrary, nothing herein shall prevent you from disclosing the fact or terms of this Agreement as part of any government investigation, or prohibit you from filing a charge,
complaint, or report with, or otherwise communicating with, providing information to, or cooperating, or participating with any investigation or proceeding by or before the Equal Employment Opportunity Commission, the United States Department of
Labor, the National Labor Relations Board, the Occupational Safety and Health Administration, the Securities and Exchange Commission, or any other federal, state or local government agency or commission. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>8.</B>&nbsp;&nbsp;&nbsp;&nbsp;<B>N<SMALL>O</SMALL> A<SMALL>DMISSIONS</SMALL>.</B><B> </B>You understand and agree that the promises and
payments in consideration of this Agreement shall not be construed to be an admission of any liability or obligation by the Company to you or to any other person, and that the Company makes no such admission. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Peter Pfreundschuh </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"> Page
 4
 </P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>9.&nbsp;&nbsp;&nbsp;&nbsp;R<SMALL>ELEASE</SMALL> <SMALL>OF</SMALL> C<SMALL>LAIMS</SMALL>.
</B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:7%; font-size:10pt; font-family:Times New Roman"><B>(a)</B>&nbsp;&nbsp;&nbsp;&nbsp;<B>General Release. </B>In exchange for the consideration provided to you under this Agreement to
which you would not otherwise be entitled, you hereby generally and completely release the Company, Parent, and each of its and their affiliated, related, parent and subsidiary entities, and each of its and their current and former directors,
officers, employees, shareholders, partners, agents, attorneys, predecessors, successors, insurers, affiliates, and assigns (collectively, the &#147;<B>Released Parties</B>&#148;) from any and all claims, liabilities and obligations, both known and
unknown, that arise out of or are in any way related to events, acts, conduct, or omissions occurring prior to or on the date you sign this Agreement (collectively, the &#147;<B>Released Claims</B>&#148;). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:7%; font-size:10pt; font-family:Times New Roman"><B>(b)</B>&nbsp;&nbsp;&nbsp;&nbsp;<B>Scope of Release. </B>The Released Claims include, but are not limited to: (i)&nbsp;all claims arising
out of or in any way related to your employment with the Company, or the termination of that employment; (ii)&nbsp;all claims related to your compensation or benefits from the Company, including salary, bonuses, commissions, vacation, expense
reimbursements, severance pay, fringe benefits, stock, stock options, or any other ownership, equity, or profits interests in the Company; (iii)&nbsp;all claims for breach of contract, wrongful termination, and breach of the implied covenant of good
faith and fair dealing; (iv)&nbsp;all tort claims, including claims for fraud, defamation, emotional distress, and discharge in violation of public policy; and (v)&nbsp;all federal, state, and local statutory claims, including claims for
discrimination, harassment, retaliation, attorneys&#146; fees, or other claims arising under the federal Civil Rights Act of 1964 (as amended), the federal Americans with Disabilities Act of 1990, the federal Age Discrimination in Employment Act of
1967 (as amended) (the &#147;<B>ADEA</B>&#148;), the New York State Human Rights Law, the New York Executive Law, the New York Civil Practice Law and Rules, the New York Judiciary Law, the New York Corrections Law, the New York Labor Law, the New
York Civil Rights Law, the New York Administrative Code, the New York City Administrative Code, the New York City Human Rights Law, the New York Hours of Labor Law, the New York Wage Payment Law, the New York Minimum Wage Act, the New York
Whistleblower Law, and the New York <FONT STYLE="white-space:nowrap">Off-Duty</FONT> Conduct Lawful Activities Discrimination Law. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:7%; font-size:10pt; font-family:Times New Roman"><B>(c)</B>&nbsp;&nbsp;&nbsp;&nbsp;<B>Excluded Claims. </B>Notwithstanding the foregoing, the following are not included in the Released Claims
(the &#147;<B>Excluded Claims</B>&#148;): (i)&nbsp;any rights or claims for indemnification you may have pursuant to any written indemnification agreement with the Company to which you are a party or under applicable law; (ii)&nbsp;any rights which
are not waivable as a matter of law (such as claims for unemployment benefits or workers compensation); and (iii)&nbsp;any claims for breach of this Agreement. In addition, nothing in this Agreement prevents you from filing, cooperating with, or
participating in any proceeding before the Equal Employment Opportunity Commission, the Department of Labor, the New York State Division of Human Rights, the New York City Commission on Human Rights, or any other government agency, except that you
acknowledge and agree that you hereby waive your right to any monetary benefits in connection with any such claim, charge or proceeding. Additionally, while this Agreement does not limit your right to receive an award for information provided to the
Securities and Exchange Commission, you are otherwise waiving, to the fullest extent permitted by law, any and all rights you may have to individual relief based on any claims that you have released and any rights you have waived by signing this
Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:7%; font-size:10pt; font-family:Times New Roman"><B>(d) </B>&nbsp;&nbsp;&nbsp;&nbsp;<B>ADEA Waiver.</B> You acknowledge that you are knowingly and voluntarily waiving and
releasing any rights you may have under the ADEA, and that the consideration given for the waiver and release in this Section is in addition to anything of value to which you are already </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Peter Pfreundschuh </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"> Page
 5
 </P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
entitled. You further acknowledge that you have been advised, as required by the ADEA, that: (i)&nbsp;your waiver and release do not apply to any rights or claims that may arise after the date
that you sign this Agreement; (ii)&nbsp;you should consult with an attorney prior to signing this Agreement (although you may choose voluntarily not to do so); (iii) you have <FONT STYLE="white-space:nowrap">twenty-one</FONT> (21)&nbsp;days to
consider this Agreement (although you may choose voluntarily to sign it earlier); (iv) you have seven (7)&nbsp;days following the date you sign this Agreement to revoke it (by providing written notice of your revocation to me); and (v)&nbsp;this
Agreement will not be effective until the date upon which the revocation period has expired, which will be the eighth day after the date that this Agreement is signed by you provided that you do not revoke it (the &#147;<B>Effective Date</B>&#148;).
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>10.</B>&nbsp;&nbsp;&nbsp;&nbsp;<B>R<SMALL>EPRESENTATIONS</SMALL>.</B> You hereby represent that you have been paid all compensation
owed and for all hours worked, have received all the leave and leave benefits and protections for which you are eligible pursuant to the Family and Medical Leave Act or otherwise, and have not suffered any <FONT STYLE="white-space:nowrap"><FONT
STYLE="white-space:nowrap">on-the-job</FONT></FONT> injury for which you have not already filed a workers&#146; compensation claim. You also acknowledge and agree that you do not possess any claim or allegation, either asserted or otherwise,
involving harassment or discrimination, that may be subject to or covered under N.Y. C.P.L.R. &#167; <FONT STYLE="white-space:nowrap">5003-b</FONT> and N.Y. General Obligations Law &#167; <FONT STYLE="white-space:nowrap">5-336.</FONT> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>11.</B>&nbsp;&nbsp;&nbsp;&nbsp;<B>C<SMALL>ONTINUING</SMALL> O<SMALL>BLIGATIONS</SMALL>;
N<SMALL>ON</SMALL><FONT STYLE="white-space:nowrap">-D</FONT><SMALL>ISPARAGEMENT</SMALL>.</B> You acknowledge that you remain bound by the Employee Proprietary Information, Inventions, <FONT STYLE="white-space:nowrap">Non-Solicitations</FONT> and <FONT
STYLE="white-space:nowrap">Non-Competition</FONT> Agreement (the &#147;<B>Confidentiality Agreement</B>&#148;) between you and the Company, attached hereto as <B>Exhibit B</B>, and agree to abide by those continuing obligations. You further
acknowledge and agree that Section&nbsp;13 of the Employment Agreement (Dispute Resolution) shall survive the termination of your employment, along with any other provisions of the Employment Agreement that by their terms are designed to survive the
termination of your employment. You also agree not to disparage the Company, its officers, directors, employees, shareholders, and agents, in any manner likely to be harmful to its or their business, business reputation, or personal reputation, and
the Company agrees to instruct its directors and officers not to disparage you in any manner likely to be harmful to your business or personal reputation; provided that any party may respond accurately and fully to any question, inquiry or request
for information when required by legal process. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>12.</B>&nbsp;&nbsp;&nbsp;&nbsp;<B>M<SMALL>ISCELLANEOUS</SMALL>.</B> This Agreement,
including its exhibits, constitutes the complete, final and exclusive embodiment of the entire agreement between you and the Company with regard to its subject matter. It is entered into without reliance on any promise or representation, written or
oral, other than those expressly contained herein, and it supersedes any other such promises, warranties or representations. This Agreement may not be modified or amended except in writing signed by both you and a duly authorized officer of the
Company. This Agreement will bind the heirs, personal representatives, successors and assigns of both you and the Company, and inure to the benefit of both you and the Company, their heirs, successors and assigns. The Company may freely assign this
Agreement, without your prior written consent. You may not assign any of your duties hereunder and you may not assign any of your rights hereunder without the written consent of the Company. If any provision of this Agreement is determined to be
invalid or unenforceable, in whole or in part, this determination will not affect any other provision of this Agreement and the provision in question will be modified so as to be rendered enforceable. This Agreement will be deemed to have
</P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Peter Pfreundschuh </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"> Page
 6
 </P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
been entered into and will be construed and enforced in accordance with the laws of the State of New York without regard to conflict of laws principles. Any ambiguity in this Agreement shall not
be construed against either party as the drafter. Any waiver of a breach of this Agreement shall be in writing and shall not be deemed to be a waiver of any successive breach. This Agreement may be executed in counterparts and facsimile signatures
and signatures transmitted by PDF will suffice as original signatures. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If this Agreement is acceptable to you, please sign below and
return the original to me. You have <FONT STYLE="white-space:nowrap">twenty-one</FONT> (21)&nbsp;calendar days to decide whether you would like to accept this Agreement, and the Company&#146;s offer contained herein will automatically expire if you
do not sign and return it within this timeframe. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We wish you the best in your future endeavors. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Sincerely, </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="7%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="92%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>U<SMALL>RO</SMALL>G<SMALL>EN</SMALL> P<SMALL>HARMA</SMALL>, I<SMALL>NC</SMALL>.</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Liz Barrett</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Liz Barrett</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">President and Chief Executive Officer</TD></TR>
</TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>E<SMALL>XHIBIT</SMALL> A &#150; Equity Summary </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>E<SMALL>XHIBIT</SMALL> B &#150; Employee Proprietary Information, Inventions, <FONT STYLE="white-space:nowrap">Non-Solicitations</FONT> and <FONT
STYLE="white-space:nowrap">Non-Competition</FONT> Agreement </B></P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>I <SMALL>HAVE</SMALL> <SMALL>READ</SMALL>, <SMALL>UNDERSTAND</SMALL>
<SMALL>AND</SMALL> <SMALL>AGREE</SMALL> <SMALL>FULLY</SMALL> <SMALL>TO</SMALL> <SMALL>THE</SMALL> <SMALL>FOREGOING</SMALL> A<SMALL>GREEMENT</SMALL>: </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="99%"></TD></TR>


<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Peter Pfreundschuh</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Peter<B> </B>Pfreundschuh</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">September&nbsp;8, 2020</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Date</TD></TR>
</TABLE>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>E<SMALL>XHIBIT</SMALL> A </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>E<SMALL>QUITY</SMALL> S<SMALL>UMMARY</SMALL> </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><I><U>Restricted Stock Awards </U></I></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="92%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="46%"></TD>

<TD VALIGN="bottom" WIDTH="9%"></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="9%"></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="9%"></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="9%"></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman"><B>Date of</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B>Grant</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Total&nbsp;Shares<BR>Granted</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Total&nbsp;Shares<BR>Vested&nbsp;as&nbsp;of&nbsp;the<BR>Separation&nbsp;Date</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Unvested&nbsp;Shares<BR>Subject&nbsp;to&nbsp;Accelerated<BR>Vesting</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Total&nbsp;Vested&nbsp;Shares</B></TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">8/20/2018</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">12,500</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">8,333</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">2,083</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">10,416</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">1/26/2019</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">5,000</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">2,500</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">833</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">3,333</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">1/31/2020</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">6,000</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">0</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">2,000</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">2,000</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><I><U>Stock Option Grants </U></I></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="92%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="53%"></TD>

<TD VALIGN="bottom" WIDTH="7%"></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="7%"></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="7%"></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="7%"></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman"><B>Date of</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B>Grant</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Total&nbsp;Shares<BR>Granted</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Total&nbsp;Shares<BR>Vested&nbsp;as&nbsp;of&nbsp;the<BR>Separation&nbsp;Date</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Unvested&nbsp;Shares<BR>Subject&nbsp;to<BR>Accelerated<BR>Vesting</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Total&nbsp;Vested<BR>Shares</B></TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">8/20/2018</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">50,000</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">33,333</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">8,333</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">41,666</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">1/26/2019</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">15,000</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">7,500</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">2,500</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">10,000</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">1/31/2020</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">15,000</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">0</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">5,000</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">5,000</TD></TR>
</TABLE>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Peter Pfreundschuh </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Page 2 </P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>E<SMALL>XHIBIT</SMALL> B </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>E<SMALL>MPLOYEE</SMALL> P<SMALL>ROPRIETARY</SMALL> I<SMALL>NFORMATION</SMALL>, I<SMALL>NVENTIONS</SMALL>, N<SMALL>ON</SMALL><FONT
STYLE="white-space:nowrap">-S</FONT><SMALL>OLICITATIONS</SMALL> <SMALL>AND</SMALL> N<SMALL>ON</SMALL>- </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>E<SMALL>MPLOYEE</SMALL>
P<SMALL>ROPRIETARY</SMALL> I<SMALL>NFORMATION</SMALL>, I<SMALL>NVENTIONS</SMALL>, N<SMALL>ON</SMALL><FONT STYLE="white-space:nowrap">-S</FONT><SMALL>OLICITATION</SMALL> </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><SMALL>AND</SMALL> N<SMALL>ON</SMALL><FONT STYLE="white-space:nowrap">-C</FONT><SMALL>OMPETITION</SMALL> A<SMALL>GREEMENT</SMALL> </B></P>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.2
<SEQUENCE>3
<FILENAME>d19897dex102.htm
<DESCRIPTION>EX-10.2
<TEXT>
<HTML><HEAD>
<TITLE>EX-10.2</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 10.2 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>EXECUTIVE EMPLOYMENT AGREEMENT </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This Executive Employment Agreement (the &#147;<B>Agreement</B>&#148;), is hereby made this
3<SUP STYLE="font-size:85%; vertical-align:top">rd</SUP> day of September, 2020, between UroGen Pharma, Inc., a wholly owned subsidiary (the &#147;<B>Subsidiary</B>&#148;) of UroGen Pharma, Ltd. (the &#147;<B>Parent</B>&#148;, and the Subsidiary and
the Parent together, the &#147;<B>Company</B>&#148;), and Molly Henderson (the &#147;<B>Executive</B>&#148;) (collectively, the &#147;<B>Parties</B>&#148;). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>W<SMALL>HEREAS</SMALL></B><SMALL></SMALL>, the Company desires for Executive to provide services to the Company, and wishes to provide
Executive with certain compensation and benefits in return for such employment services; and </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>W<SMALL>HEREAS</SMALL></B><SMALL></SMALL>, Executive wishes to be employed by the Company and to provide personal services to the Company
in return for certain compensation and benefits; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>N<SMALL>OW</SMALL>, T<SMALL>HEREFORE</SMALL></B><SMALL></SMALL>, in consideration of
the mutual promises and covenants contained herein and for other good and valuable consideration, the receipt and sufficiency of which is hereby acknowledged, the Parties hereto agree as follows: </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>1.&nbsp;&nbsp;&nbsp;&nbsp;Employment by the Company. </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>1.1</B>&nbsp;&nbsp;&nbsp;&nbsp;<B>Position.</B> Executive shall serve as the Company&#146;s Chief Financial Officer. Executive&#146;s
employment with the Company shall commence on October&nbsp;1, 2020 (the &#147;<B>Start Date</B>&#148;). During Executive&#146;s employment with the Company, Executive will devote Executive&#146;s best efforts and substantially all of
Executive&#146;s business time and attention to the business of the Company, except for (i)&nbsp;approved outside activities (<I>e.g.</I>, existing board positions, charitable activities, conferences, events, etc.), and (ii)&nbsp;approved vacation
periods, reasonable periods of illness or other incapacities permitted by the Company&#146;s general employment policies, and as otherwise permitted by this Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>1.2</B>&nbsp;&nbsp;&nbsp;&nbsp;<B>Duties and Location.</B> Executive shall perform such duties as are typically required by a Chief
Financial Officer, including, in coordination with department heads, alignment and execution oversight of the Company&#146;s key efforts in order to help meet its short and long-term business goals and objectives and measuring and reporting on the
Company&#146;s operational performance. Executive will report to the Company&#146;s Chief Executive Officer. Executive&#146;s primary work location will be the Company&#146;s Princeton, NJ office (or company&#146;s corporate headquarters location)
and Executive&#146;s home office, as mutually agreed </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>1.3</B>&nbsp;&nbsp;&nbsp;&nbsp;<B>Policies and Procedures.</B> The employment
relationship between the Parties shall be governed by the general employment policies and practices of the Company, except that when the terms of this Agreement differ from, or are in conflict with, the Company&#146;s general employment policies or
practices, this Agreement shall control. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>2.&nbsp;&nbsp;&nbsp;&nbsp;Compensation. </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>2.1</B>&nbsp;&nbsp;&nbsp;&nbsp;<B>Salary.</B> For services to be rendered hereunder, Executive shall receive a base salary at the rate of
$430,000.00 per year (the &#147;<B>Base Salary</B>&#148;), subject to standard payroll deductions and withholdings and payable in accordance with the Company&#146;s regular payroll schedule. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>2.2</B>&nbsp;&nbsp;&nbsp;&nbsp;<B>Signing Bonus.</B> The Company will pay Executive a <FONT STYLE="white-space:nowrap">one-time</FONT>
Signing Bonus of $100,000.00, and such payment is subject to standard payroll deductions and withholdings (the &#147;Signing Bonus&#148;). The Signing Bonus will be paid to Executive in advance of being earned, within thirty (30)&nbsp;days after
Executive&#146;s Start Date. Executive will earn the Signing Bonus if Executive remains continuously employed with the Company through the <FONT STYLE="white-space:nowrap">one-year</FONT> anniversary of the Start Date. If Executive resigns from
employment with the company without Good Reason or the Company terminates Executive&#146;s employment for Cause, in each case prior to the first anniversary of the Start Date, Executive must repay the Signing Bonus in full to the Company within ten
(10)&nbsp;business days after the date on which Executive&#146;s employment terminates. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>2.3</B>&nbsp;&nbsp;&nbsp;&nbsp;<B>Annual
Bonus.</B> Executive will be eligible for an annual discretionary bonus, with an annual target of 50% of Executive&#146;s Base Salary (the &#147;<B>Annual Bonus</B>&#148;),<B> </B><FONT STYLE="white-space:nowrap">pro-rated</FONT> in the case of a
partial calendar year. Whether Executive receives an Annual Bonus for any given year, and the amount of any such Annual Bonus, will be determined by the Company, with input from the Company&#146;s Board of Directors, in its sole discretion based
upon the Company&#146;s and Executive&#146;s achievement of goals and objectives to be determined on an annual basis by the Company in a manner consistent with other senior management. Except as outlined in Section&nbsp;5.2, Executive must remain an
active employee through the end of any given calendar year in order to earn an Annual Bonus for that year and any such bonus will be paid prior to March&nbsp;15 of the following year. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>3.</B>&nbsp;&nbsp;&nbsp;&nbsp;<B>Standard Company Benefits. </B>Executive shall be eligible to participate in all employee benefit programs
which are made available generally to the Company&#146;s U.S.-based senior executive group, on a basis comparable to such group. Employee shall be eligible to receive two hundred (200)&nbsp;hours of paid time off (PTO) hours annually, in accordance
with the Company&#146;s paid time off policy. The Company reserves the right to cancel or change the benefit plans or programs it offers to its employees at any time, provided that such cancellation or change is generally applicable to the
Company&#146;s U.S.-based senior executive group participating in such plan or program. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>4.&nbsp;&nbsp;&nbsp;&nbsp;Equity. </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>4.1</B>&nbsp;&nbsp;&nbsp;&nbsp;Subject to approval by the Board of Directors of the Parent, Executive shall be granted an option to purchase
60,000 of the Company&#146;s ordinary shares, par value NIS 0.01 (the &#147;<B>Ordinary Shares</B>&#148;) in the Parent at the fair market value on the date of grant (the &#147;<B>Option</B>&#148;) and 15,000 restricted stock units of the Parent
(the &#147;<B>RSU</B>&#148;). The Option and RSU shall be governed in all respects by the terms of the governing plan documents and option and restricted stock agreements between Executive and the Parent. Employee equity
</P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
grants are made periodically at the discretion of the board of directors, typically on a quarterly basis. These equity grants are intended to be a material inducement to Executive&#146;s
acceptance of employment with the company. The Option and RSU will vest over 3 years - 1/3 will vest on the first anniversary of the Vesting Commencement Date, and 1/3 of the Option and RSU will vest annually thereafter for the remaining two
(2)&nbsp;years. Executive will be eligible for consideration for annual grants of additional equity awards pursuant to the process applicable to other members of the executive leadership team, with the terms of any such grants to be determined in
the sole discretion of the Board. Target value of annual awards are at the discretion of the board but will target range equal to target bonus value. i.e. 50% of annual salary. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>5.&nbsp;&nbsp;&nbsp;&nbsp;Termination of Employment; Severance. </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>5.1</B>&nbsp;&nbsp;&nbsp;&nbsp;<B><FONT STYLE="white-space:nowrap">At-Will</FONT> Employment.</B> Executive&#146;s employment relationship
is <FONT STYLE="white-space:nowrap">at-will.</FONT> Either Executive or the Company may terminate the employment relationship at any time, with or without Cause or advance notice. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>5.2&nbsp;&nbsp;&nbsp;&nbsp;Termination By Company Without Cause; Termination by Executive With Good Reason; Death or Disability </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman"><B>(i)</B>&nbsp;&nbsp;&nbsp;&nbsp;The Company may terminate Executive&#146;s employment with the Company at any time without Cause (as defined
below). Executive may terminate his/her employment at any time for Good Reason, as defined below. Executive&#146;s employment with the Company may also be terminated due to Executive&#146;s death or Disability. For this purpose,
&#147;<B>Disability</B>&#148; shall mean that Executive is unable to engage in any substantial gainful activity by reason of any medically determinable physical or mental impairment that can be expected to result in death or can be expected to last
for a continuous period of not less than 12 months, and shall be determined in the good faith and reasonable discretion of the Board. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman"><B>(ii)</B>&nbsp;&nbsp;&nbsp;&nbsp;In the event Executive&#146;s employment with the Company is terminated by the Company without Cause, by
Executive for Good Reason, or by reason of Executive&#146;s death or Disability, then provided such termination constitutes a &#147;separation from service&#148; (as defined under Treasury Regulation
<FONT STYLE="white-space:nowrap">Section&nbsp;1.409A-1(h),</FONT> without regard to any alternative definition thereunder, a &#147;<B>Separation from Service</B>&#148;), and provided that Executive remains in compliance with the terms of this
Agreement, the Company shall provide Executive with the following Severance Benefits: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:18%; font-size:10pt; font-family:Times New Roman"><B>(a)</B>&nbsp;&nbsp;&nbsp;&nbsp;The Company
shall pay Executive, as severance, the equivalent of six (6)&nbsp;months of Executive&#146;s base salary in effect as of the date of Executive&#146;s employment termination (without taking into account any reduction in salary constituting Good
Reason), subject to standard payroll deductions and withholdings (the &#147;<B>Severance</B>&#148;). The Severance will be paid as a continuation on the Company&#146;s regular payroll, beginning on the sixtieth (60<SUP
STYLE="font-size:85%; vertical-align:top">th</SUP>) day following Executive&#146;s Separation from Service, provided the Separation Agreement (as discussed in Paragraph 6) has become effective. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:18%; font-size:10pt; font-family:Times New Roman"><B>(b)</B>&nbsp;&nbsp;&nbsp;&nbsp;The Company shall pay Executive a <FONT
STYLE="white-space:nowrap">pro-rata</FONT> bonus through the date of termination, which bonus shall be paid only to the extent earned based on actual Company performance, not to exceed 100% of the target (with any individual performance component
deemed achieved), on the date in the year following termination on which bonuses are paid to other senior executives of the Company (but in any event prior to March&nbsp;15 of such year), provided the Separation Agreement (as discussed in Paragraph
6) has become effective. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:18%; font-size:10pt; font-family:Times New Roman"><B>(c)</B>&nbsp;&nbsp;&nbsp;&nbsp;The Company shall pay Executive any annual bonus earned with respect to the
year preceding the year of termination, if not already paid by the date of termination, which amount shall be paid on the sixtieth (60<SUP STYLE="font-size:85%; vertical-align:top">th</SUP>) day following Executive&#146;s Separation from Service,
provided the Separation Agreement (as discussed in Paragraph 6) has become effective. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:18%; font-size:10pt; font-family:Times New Roman"><B>(d)</B>&nbsp;&nbsp;&nbsp;&nbsp;The vesting of
any of Executive&#146;s unvested restricted shares and options, including the Option, shall be accelerated by one (1)&nbsp;quarter, such that 8.33% of the then-unvested restricted shares and options shall be deemed immediately vested and exercisable
as of Executive&#146;s last day of employment. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:18%; font-size:10pt; font-family:Times New Roman"><B>(e)</B>&nbsp;&nbsp;&nbsp;&nbsp;The Company shall reimburse Executive the amount of any
COBRA continuation premium payments made by Executive during the six (6)&nbsp;month period following the date of termination, or the period ending when Executive becomes eligible for comparable group medical benefits coverage from another source
(whichever comes first). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>5.3&nbsp;&nbsp;&nbsp;&nbsp;Resignation by Executive Without Good Reason; Termination by the Company for Cause
</B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman"><B>(i)</B>&nbsp;&nbsp;&nbsp;&nbsp;The Company may terminate Executive&#146;s employment with the Company at any time for Cause and
Executive may resign at any time. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman"><B>(ii)</B>&nbsp;&nbsp;&nbsp;&nbsp;If Executive resigns or the Company terminates Executive&#146;s
employment for Cause, then (i)&nbsp;Executive will no longer vest in additional unvested portions in the Option and the RSU, (ii)&nbsp;all payments of compensation by the Company to Executive hereunder will terminate immediately (except as to
amounts already earned), and (c)&nbsp;Executive will not be entitled to any Severance Benefits. In addition, Executive shall resign from all positions and terminate any relationships as an employee, advisor, officer or director with the Company and
any of its affiliates, each effective on the date of termination.<B> </B> </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>6.</B>&nbsp;&nbsp;&nbsp;&nbsp;<B>Conditions to Receipt of
Severance Benefits.</B> The receipt of the Severance Benefits will be subject to Executive signing and not revoking a separation agreement and release of claims in a form reasonably satisfactory to the Company (the &#147;<B>Separation
Agreement</B>&#148;). No Severance Benefits will be paid or provided until the Separation Agreement becomes effective. Executive shall also resign from all positions and terminate any relationships as an employee, advisor, officer or director with
the Company and any of its affiliates, each effective on the date of termination. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>7.&nbsp;&nbsp;&nbsp;&nbsp;Benefits in Connection with a Change of Control. </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>7.1</B>&nbsp;&nbsp;&nbsp;&nbsp;<B>Termination of Employment in Connection with a Change of Control. </B>If there is a Change of Control (as
defined below) and (i)&nbsp;Executive&#146;s employment is terminated Without Cause (as defined below), or (ii)&nbsp;Executive terminates his/her employment with Good Reason (as defined below), in either case within three (3)&nbsp;months prior to,
or twenty-four (24)&nbsp;months following the effective date of the Change of Control, and provided a Separation Agreement (as discussed in Section&nbsp;6) has become effective, then, in substitution for any benefits provided in Section&nbsp;5.2,
Executive shall be entitled to the following benefits: (A)&nbsp;a lump sum payment equal to the sum of (y) 12 months of Executive&#146;s then-current annual Base Salary and (z) 100% of the current target bonus percentage of Executive&#146;s current
annual Base Salary, to be made not later than 60 days following Executive&#146;s date of termination; and (B)&nbsp;the amount of any COBRA continuation premium payments made by Executive during the twelve (12)&nbsp;month period following the date of
termination, or the period ending when Executive becomes eligible for comparable group medical benefits from another source (whichever comes first). For avoidance of doubt, under no circumstances shall Executive receive benefits under both this
Section&nbsp;7.1 and Section&nbsp;5.2. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>7.2</B>&nbsp;&nbsp;&nbsp;&nbsp;<B>Acceleration of Options; Change of Control. </B>If the
Company terminates Executive&#146;s employment with the Company without Cause, or Executive resigns for Good Reason, in either case within three (3)&nbsp;months prior to, or twenty-four (24)&nbsp;months following the closing of a Change of Control
(as defined below), then in addition to the benefits set forth in Section&nbsp;7.1 and pursuant to the terms of Section&nbsp;6, the Company will fully accelerate the vesting of the Options and the RSU, as well as any other equity interests granted
to Executive, such that 100% of the then-unvested shares subject to the Options and the RSU (or other equity interests) will be deemed vested and exercisable as of Executive&#146;s last day of employment. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>8.</B>&nbsp;&nbsp;&nbsp;&nbsp;<B>Section 409A.</B> It is intended that all of the Severance Benefits and other payments payable under this
Agreement satisfy, to the greatest extent possible, the exemptions from the application of Code Section&nbsp;409A provided under Treasury Regulations <FONT STYLE="white-space:nowrap">1.409A-1(b)(4),</FONT>
<FONT STYLE="white-space:nowrap">1.409A-1(b)(5)</FONT> and <FONT STYLE="white-space:nowrap">1.409A-1(b)(9),</FONT> and this Agreement will be construed to the greatest extent possible as consistent with those provisions, and to the extent not so
exempt, this Agreement (and any definitions hereunder) will be construed in a manner that complies with Section&nbsp;409A. For purposes of Code Section&nbsp;409A (including, without limitation, for purposes of Treasury Regulation <FONT
STYLE="white-space:nowrap">Section&nbsp;1.409A-2(b)(2)(iii)),</FONT> Executive&#146;s right to receive any installment payments under this Agreement (whether severance payments, reimbursements or otherwise) shall be treated as a right to receive a
series of separate payments and, accordingly, each installment payment hereunder shall at all times be considered a separate and distinct payment. Notwithstanding any provision to the contrary in this Agreement, if Executive is deemed by the Company
at the time of Executive&#146;s Separation from Service to be a &#147;specified employee&#148; for purposes of Code Section&nbsp;409A(a)(2)(B)(i), and if any of the payments upon Separation from Service set forth herein and/or under any other
agreement with the Company are deemed to be &#147;deferred </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
compensation&#148;, then to the extent delayed commencement of any portion of such payments is required in order to avoid a prohibited distribution under Code Section&nbsp;409A(a)(2)(B)(i) and
the related adverse taxation under Section&nbsp;409A, such payments shall not be provided to Executive prior to the earliest of (i)&nbsp;the expiration of the <FONT STYLE="white-space:nowrap">six-month</FONT> period measured from the date of
Executive&#146;s Separation from Service with the Company, (ii)&nbsp;the date of Executive&#146;s death or (iii)&nbsp;such earlier date as permitted under Section&nbsp;409A without the imposition of adverse taxation. Upon the first business day
following the expiration of such applicable Code Section&nbsp;409A(a)(2)(B)(i) period, all payments deferred pursuant to this Paragraph shall be paid in a lump sum to Executive, and any remaining payments due shall be paid as otherwise provided
herein or in the applicable agreement. No interest shall be due on any amounts so deferred. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>9.&nbsp;&nbsp;&nbsp;&nbsp;Definitions.
</B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>9.1</B>&nbsp;&nbsp;&nbsp;&nbsp;<B>Change of Control</B>. For purposes of this Agreement, &#147;<B>Change of Control</B>&#148; shall
mean: the acquisition of the Company or the Parent by another entity by means of any transaction or series of related transactions approved by the Board of Directors of the Parent to which the Parent is party (including, without limitation, any
stock acquisition, reorganization, merger or consolidation, but excluding any sale of stock for capital raising purposes) other than a transaction or series of transactions in which the holders of the voting securities of the Parent outstanding
immediately prior to such transaction continue to retain (either by such voting securities remaining outstanding or by such voting securities being converted into voting securities of the surviving entity), as a result of Ordinary Shares in the
Company held by such holders prior to such transaction, at least fifty percent (50%) of the total voting power represented by the voting securities of the Company or such surviving entity outstanding immediately after such transaction or series of
transactions. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>9.2</B>&nbsp;&nbsp;&nbsp;&nbsp;<B>Cause.</B> For purposes of this Agreement, &#147;<B>Cause</B>&#148; for termination
will mean: (a)&nbsp;commission of any felony, or other crime involving dishonesty; (b)&nbsp;participation in any fraud against the Company; (c)&nbsp;material breach of Executive&#146;s duties to the Company; (d)&nbsp;intentional and material damage
to any property of the Company; (e)&nbsp;misconduct or other violation of Company policy that causes material harm to the Company; (f)&nbsp;material breach of any material written agreement with the Company or any material written Company policy;
and (g)&nbsp;conduct by Executive which in the good faith and reasonable determination by the Board of Directors demonstrates gross unfitness to serve. An event described in (c), (d), (f) and (g)&nbsp;shall not be treated as &#147;Cause&#148; until
after Executive has been given written notice of such event, failure, conduct or breach and Executive fails to cure such event, failure, conduct or breach within 30 days from such written notice; provided, however, that such <FONT
STYLE="white-space:nowrap">30-day</FONT> cure period shall not be required if the event, failure, conduct or breach is incapable of being cured. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>9.3&nbsp;&nbsp;&nbsp;&nbsp;</B><B>Good Reason.</B> For purposes of this Agreement, &#147;<B>Good Reason</B>&#148; for resignation will
mean: (a)&nbsp;a material reduction in Executive&#146;s responsibilities, authorities, title or reporting relationship; (b)&nbsp;the requirement that Executive routinely report to work at a location that is greater than 50 miles from her current
residence; or (c)&nbsp;material breach by </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
the Company of any material agreement between Executive and the Company, including this Agreement.&nbsp;In order for Executive to resign for Good Reason, Executive must provide written notice to
the Company&#146;s Board or Chief Executive Officer within 90 days after the first occurrence of the event giving rise to Good Reason setting forth the basis for Executive&#146;s resignation. Executive must then allow the Company at least 45 days
from receipt of such written notice to cure such event, and if such event is not reasonably cured by the Company within such 45 day period (the &#147;<B>Cure Period</B>&#148;), Executive must then resign from all positions Executive then holds with
the Company not later than 90 days after the expiration of the Cure Period. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>10.</B>&nbsp;&nbsp;&nbsp;&nbsp;<B>Proprietary Information
Obligations. </B>In connection with Executive&#146;s employment with the Company, Executive will receive and have access to Company confidential information and trade secrets.&nbsp;Accordingly, enclosed with this Agreement is an Employee Proprietary
Information, Inventions, <FONT STYLE="white-space:nowrap">Non-Solicitation</FONT> and <FONT STYLE="white-space:nowrap">Non-Competition</FONT> Agreement (the &#147;<B>Confidentiality Agreement</B>&#148;) which contains restrictive covenants and
prohibits unauthorized use or disclosure of the Company&#146;s confidential information and trade secrets, among other obligations. Executive agrees to review the Confidentiality Agreement and only sign it after careful consideration. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>11.&nbsp;&nbsp;&nbsp;&nbsp;Outside Activities During Employment </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>11.1</B>&nbsp;&nbsp;&nbsp;&nbsp;<B><FONT STYLE="white-space:nowrap">Non-Company</FONT> Business. </B>Except with the prior written consent
of the Company, which will not unreasonably be withheld, Executive will not during the term of Executive&#146;s employment with the Company undertake or engage in any other employment, occupation or business enterprise, other than ones in which
Executive is a passive investor or received written clearance from the Company. Executive may engage in civic and <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">not-for-profit</FONT></FONT> activities, so long as such activities
do not materially interfere with the performance of Executive&#146;s duties hereunder. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>12.</B>&nbsp;&nbsp;&nbsp;&nbsp;<B>Dispute
Resolution. </B>To ensure the timely and economical resolution of disputes that may arise in connection with Executive&#146;s employment with the Company, Executive and the Company agree that any and all disputes, claims, or causes of action arising
from or relating to the enforcement, breach, performance, negotiation, execution, or interpretation of this Agreement, the Confidentiality Agreement, or Executive&#146;s employment, or the termination of Executive&#146;s employment, including but
not limited to all statutory claims, with the exception of discrimination and harassment claims, will be resolved pursuant to the Federal Arbitration Act, 9 U.S.C. <FONT STYLE="white-space:nowrap">&#167;1-16</FONT> (the &#147;<B>FAA</B>&#148;), and
to the fullest extent permitted by law, by final, binding and confidential arbitration by a single arbitrator conducted in New York, New York by Judicial Arbitration and Mediation Services Inc. (&#147;<B>JAMS</B>&#148;) under the then applicable
JAMS rules (at the following web address: <U>https://www.jamsadr.com/rules-employment-arbitration/</U>); provided, however, this arbitration provision shall not apply to sexual harassment and discrimination claims to the extent prohibited by
applicable law that is not preempted by the FAA (collectively, &#147;<B>Excluded</B> <B>Claims</B>&#148;). A hard copy of the rules will be provided to Executive upon request. A hard copy of the rules will be provided to Executive upon request. By
agreeing to this arbitration procedure, both Executive and the Company waive the right to resolve any such </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
dispute through a trial by jury or judge or administrative proceeding. In addition, all claims, disputes, or causes of action under this section, whether by Executive or the Company, must be
brought in an individual capacity, and shall not be brought as a plaintiff (or claimant) or class member in any purported class or representative proceeding, nor joined or consolidated with the claims of any other person or entity. The Arbitrator
may not consolidate the claims of more than one person or entity, and may not preside over any form of representative or class proceeding. To the extent that the preceding sentences regarding class claims or proceedings are found to violate
applicable law or are otherwise found unenforceable, any claim(s) alleged or brought on behalf of a class shall proceed in a court of law rather than by arbitration. The Company acknowledges that Executive will have the right to be represented by
legal counsel at any arbitration proceeding. Questions of whether a claim is subject to arbitration under this Agreement) shall be decided by a federal court in the State of New York. However, procedural questions which grow out of the dispute and
bear on the final disposition are matters for the arbitrator. The arbitrator shall: (a)&nbsp;have the authority to compel adequate discovery for the resolution of the dispute and to award such relief as would otherwise be permitted by law;
(b)&nbsp;issue a written arbitration decision, to include the arbitrator&#146;s essential findings and conclusions and a statement of the award; and (c)&nbsp;be authorized to award any or all remedies that Executive or the Company would be entitled
to seek in a court of law. Executive and the Company shall equally share all JAMS&#146; arbitration fees. To the extent JAMS does not collect or Executive otherwise does not pay to JAMS an equal share of all JAMS&#146; arbitration fees for any
reason, and the Company pays JAMS Executive&#146;s share, Executive acknowledges and agrees that the Company shall be entitled to recover from Executive half of the JAMS arbitration fees invoiced to the parties (less any amounts Executive paid to
JAMS) in a federal or state court of competent jurisdiction. Except as modified in the Confidentiality Agreement, each party is responsible for its own attorneys&#146; fees. Nothing in this Agreement is intended to prevent either Executive or the
Company from obtaining injunctive relief in court to prevent irreparable harm pending the conclusion of any such arbitration. Any awards or orders in such arbitrations may be entered and enforced as judgments in the federal and state courts of any
competent jurisdiction. To the extent applicable law prohibits mandatory arbitration of Excluded Claims and is not preempted by the FAA, in the event Executive intends to bring multiple claims, including one or more Excluded Claims, the Excluded
Claim(s) may be publicly filed with a court, while any other claims will remain subject to mandatory arbitration. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>13.&nbsp;&nbsp;&nbsp;&nbsp;General Provisions. </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>13.1</B>&nbsp;&nbsp;&nbsp;&nbsp;<B>Notices.</B> Any notices provided must be in writing and will be deemed effective upon the earlier of
personal delivery (including personal delivery by fax) or the next day after sending by overnight carrier, to the Company at its primary office location and to Executive at the address as listed on the Company payroll. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>13.2</B>&nbsp;&nbsp;&nbsp;&nbsp;<B>Severability.</B> Whenever possible, each provision of this Agreement will be interpreted in such manner
as to be effective and valid under applicable law, but if any provision of this Agreement is held to be invalid, illegal or unenforceable in any respect under any applicable law or rule in any jurisdiction, such invalidity, illegality or
</P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
unenforceability will not affect any other provision or any other jurisdiction, but this Agreement will be reformed, construed and enforced in such jurisdiction to the extent possible in keeping
with the intent of the parties. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>13.3</B>&nbsp;&nbsp;&nbsp;&nbsp;<B>Waiver.</B> Any waiver of any breach of any provisions of this
Agreement must be in writing to be effective, and it shall not thereby be deemed to have waived any preceding or succeeding breach of the same or any other provision of this Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>13.4</B>&nbsp;&nbsp;&nbsp;&nbsp;<B>Complete Agreement.</B> This Agreement, together with the Confidentiality Agreement, constitutes the
entire agreement between Executive and the Company with regard to this subject matter and is the complete, final, and exclusive embodiment of the Parties&#146; agreement with regard to this subject matter. This Agreement is entered into without
reliance on any promise or representation, written or oral, other than those expressly contained herein, and it supersedes any other such promises, warranties or representations. It is entered into without reliance on any promise or representation
other than those expressly contained herein, and it cannot be modified or amended except in a writing signed by a duly authorized officer of the Company. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>13.5</B>&nbsp;&nbsp;&nbsp;&nbsp;<B>Counterparts.</B> This Agreement may be executed in separate counterparts, any one of which need not
contain signatures of more than one party, but all of which taken together will constitute one and the same Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>13.6</B>&nbsp;&nbsp;&nbsp;&nbsp;<B>Headings.</B> The headings of the paragraphs hereof are inserted for convenience only and shall not be
deemed to constitute a part hereof nor to affect the meaning thereof. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>13.7</B>&nbsp;&nbsp;&nbsp;&nbsp;<B>Successors and Assigns.</B>
This Agreement is intended to bind and inure to the benefit of and be enforceable by Executive and the Company, and their respective successors, assigns, heirs, executors and administrators, except that Executive may not assign any of his/her duties
hereunder and he/she may not assign any of his/her rights hereunder without the written consent of the Company, which shall not be withheld unreasonably. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>13.8</B>&nbsp;&nbsp;&nbsp;&nbsp;<B>Tax Withholding and Indemnification.</B> All payments and awards contemplated or made pursuant to this
Agreement will be subject to withholdings of applicable taxes in compliance with all relevant laws and regulations of all appropriate government authorities. Executive acknowledges and agrees that the Company has neither made any assurances nor any
guarantees concerning the tax treatment of any payments or awards contemplated by or made pursuant to this Agreement. Executive has had the opportunity to retain a tax and financial advisor and fully understands the tax and economic consequences of
all payments and awards made pursuant to the Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>13.9</B>&nbsp;&nbsp;&nbsp;&nbsp;<B>Insurance and Indemnification.</B> The
Company agrees to indemnify Executive in accordance with Company policy and applicable laws with respect to any acts or omissions Executive may have committed in his/her capacity as an office holder of the Company, and to include his/her in the
Company&#146;s existing D&amp;O insurance policy in accordance with Company policy and applicable laws. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>13.10</B>&nbsp;&nbsp;&nbsp;&nbsp;<B> Choice of Law.</B> All questions concerning the
construction, validity and interpretation of this Agreement will be governed by the laws of the State of New York. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>I<SMALL>N</SMALL>
W<SMALL>ITNESS</SMALL> W<SMALL>HEREOF</SMALL></B><SMALL></SMALL>, the Parties have executed this Agreement on the day and year first written above. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="7%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="92%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>U<SMALL>RO</SMALL>G<SMALL>EN</SMALL> P<SMALL>HARMA</SMALL>, I<SMALL>NC</SMALL>.</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Liz Barrett</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"><B>Liz Barrett</B></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"><B>Chief Executive Officer</B></TD></TR>
</TABLE></DIV> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="100%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>E<SMALL>XECUTIVE</SMALL></B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Molly Henderson</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>Molly Henderson</B></TD></TR>
</TABLE></DIV>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>4
<FILENAME>urgn-20200903.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!-- DFIN - https://www.dfinsolutions.com/ -->
<!-- CTU Version: Release 2020-5 Build:20200707.2 -->
<!-- Creation date: 9/9/2020 11:11:07 AM Eastern Time -->
<!-- Copyright (c) 2020 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<xsd:schema
  xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric"
  xmlns:num="http://www.xbrl.org/dtr/type/numeric"
  xmlns:us-types="http://fasb.org/us-types/2019-01-31"
  xmlns:urgn="http://www.urogen.com/20200903"
  xmlns:dei="http://xbrl.sec.gov/dei/2019-01-31"
  xmlns:xbrli="http://www.xbrl.org/2003/instance"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xbrldt="http://xbrl.org/2005/xbrldt"
  xmlns:sic="http://xbrl.sec.gov/sic/2011-01-31"
  attributeFormDefault="unqualified"
  elementFormDefault="qualified"
  targetNamespace="http://www.urogen.com/20200903"
  xmlns:xsd="http://www.w3.org/2001/XMLSchema">
    <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/instance" />
    <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/linkbase" />
    <xsd:import schemaLocation="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd" namespace="http://xbrl.sec.gov/dei/2019-01-31" />
    <xsd:import schemaLocation="http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd" namespace="http://www.xbrl.org/dtr/type/numeric" />
    <xsd:import schemaLocation="http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd" namespace="http://www.xbrl.org/dtr/type/non-numeric" />
    <xsd:import schemaLocation="http://xbrl.sec.gov/sic/2011/sic-2011-01-31.xsd" namespace="http://xbrl.sec.gov/sic/2011-01-31" />
    <xsd:import schemaLocation="https://xbrl.sec.gov/naics/2017/naics-2017-01-31.xsd" namespace="http://xbrl.sec.gov/naics/2017-01-31" />
    <xsd:import schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" namespace="http://xbrl.org/2005/xbrldt" />
  <xsd:annotation>
    <xsd:appinfo>
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="urgn-20200903_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:title="Label Links, all" xlink:type="simple" />
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="urgn-20200903_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:title="Presentation Links, all" xlink:type="simple" />
      <link:roleType roleURI="http://www.urogen.com//20200903/taxonomy/role/DocumentDocumentAndEntityInformation" id="Role_DocumentDocumentAndEntityInformation">
        <link:definition>100000 - Document - Document and Entity Information</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xsd:appinfo>
  </xsd:annotation>
</xsd:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>5
<FILENAME>urgn-20200903_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<!-- DFIN - https://www.dfinsolutions.com/ -->
<!-- CTU Version: Release 2020-5 Build:20200707.2 -->
<!-- Creation date: 9/9/2020 11:11:07 AM Eastern Time -->
<!-- Copyright (c) 2020 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<link:linkbase
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
  xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CoverAbstract" xlink:type="locator" xlink:label="dei_CoverAbstract" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_CoverAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Cover [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_CoverAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cover [Abstract]</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_AmendmentFlag" xlink:type="locator" xlink:label="dei_AmendmentFlag" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_AmendmentFlag_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Amendment Flag</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_AmendmentFlag_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Amendment Flag</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityCentralIndexKey" xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Central Index Key</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Central Index Key</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentType" xlink:type="locator" xlink:label="dei_DocumentType" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentType_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Document Type</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_DocumentType_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Type</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentPeriodEndDate" xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Document Period End Date</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Period End Date</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityRegistrantName" xlink:type="locator" xlink:label="dei_EntityRegistrantName" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityRegistrantName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Registrant Name</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityRegistrantName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Registrant Name</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityIncorporationStateCountryCode" xlink:type="locator" xlink:label="dei_EntityIncorporationStateCountryCode" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Incorporation State Country Code</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Incorporation State Country Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityFileNumber" xlink:type="locator" xlink:label="dei_EntityFileNumber" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityFileNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity File Number</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityFileNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity File Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityTaxIdentificationNumber" xlink:type="locator" xlink:label="dei_EntityTaxIdentificationNumber" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Tax Identification Number</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Tax Identification Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressAddressLine1" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine1" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Address Line One</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Address Line One</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressAddressLine2" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine2" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine2_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Address Line Two</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine2_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Address Line Two</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressCityOrTown" xlink:type="locator" xlink:label="dei_EntityAddressCityOrTown" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, City or Town</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, City or Town</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressStateOrProvince" xlink:type="locator" xlink:label="dei_EntityAddressStateOrProvince" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, State or Province</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, State or Province</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressPostalZipCode" xlink:type="locator" xlink:label="dei_EntityAddressPostalZipCode" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Postal Zip Code</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CityAreaCode" xlink:type="locator" xlink:label="dei_CityAreaCode" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_CityAreaCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">City Area Code</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_CityAreaCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">City Area Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_LocalPhoneNumber" xlink:type="locator" xlink:label="dei_LocalPhoneNumber" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_LocalPhoneNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Local Phone Number</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_LocalPhoneNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Local Phone Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_WrittenCommunications" xlink:type="locator" xlink:label="dei_WrittenCommunications" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_WrittenCommunications_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Written Communications</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_WrittenCommunications_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Written Communications</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_SolicitingMaterial" xlink:type="locator" xlink:label="dei_SolicitingMaterial" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_SolicitingMaterial_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Soliciting Material</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_SolicitingMaterial_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Soliciting Material</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_PreCommencementTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementTenderOffer" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Pre Commencement Tender Offer</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Pre Commencement Tender Offer</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_PreCommencementIssuerTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementIssuerTenderOffer" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Pre Commencement Issuer Tender Offer</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Pre Commencement Issuer Tender Offer</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_Security12bTitle" xlink:type="locator" xlink:label="dei_Security12bTitle" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_Security12bTitle_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Security 12b Title</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_Security12bTitle_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Security 12b Title</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_TradingSymbol" xlink:type="locator" xlink:label="dei_TradingSymbol" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_TradingSymbol_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Trading Symbol</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_TradingSymbol_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Trading Symbol</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_SecurityExchangeName" xlink:type="locator" xlink:label="dei_SecurityExchangeName" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_SecurityExchangeName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Security Exchange Name</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_SecurityExchangeName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Security Exchange Name</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityEmergingGrowthCompany" xlink:type="locator" xlink:label="dei_EntityEmergingGrowthCompany" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Emerging Growth Company</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Emerging Growth Company</link:label>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>6
<FILENAME>urgn-20200903_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<!-- DFIN - https://www.dfinsolutions.com/ -->
<!-- CTU Version: Release 2020-5 Build:20200707.2 -->
<!-- Creation date: 9/9/2020 11:11:07 AM Eastern Time -->
<!-- Copyright (c) 2020 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<link:linkbase
    xmlns:link="http://www.xbrl.org/2003/linkbase"
    xmlns:xlink="http://www.w3.org/1999/xlink"
    xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
    xmlns:xbrldt="http://xbrl.org/2005/xbrldt"
    xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.urogen.com//20200903/taxonomy/role/DocumentDocumentAndEntityInformation" xlink:href="urgn-20200903.xsd#Role_DocumentDocumentAndEntityInformation" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.urogen.com//20200903/taxonomy/role/DocumentDocumentAndEntityInformation">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CoverAbstract" xlink:type="locator" xlink:label="dei_CoverAbstract" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_AmendmentFlag" xlink:type="locator" xlink:label="dei_AmendmentFlag" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_AmendmentFlag" order="22.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityCentralIndexKey" xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityCentralIndexKey" order="23.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentType" xlink:type="locator" xlink:label="dei_DocumentType" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentType" order="25.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentPeriodEndDate" xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentPeriodEndDate" order="26.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityRegistrantName" xlink:type="locator" xlink:label="dei_EntityRegistrantName" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityRegistrantName" order="27.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityIncorporationStateCountryCode" xlink:type="locator" xlink:label="dei_EntityIncorporationStateCountryCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityIncorporationStateCountryCode" order="28.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityFileNumber" xlink:type="locator" xlink:label="dei_EntityFileNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityFileNumber" order="29.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityTaxIdentificationNumber" xlink:type="locator" xlink:label="dei_EntityTaxIdentificationNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityTaxIdentificationNumber" order="30.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressAddressLine1" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine1" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressAddressLine1" order="31.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressAddressLine2" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine2" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressAddressLine2" order="32.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressCityOrTown" xlink:type="locator" xlink:label="dei_EntityAddressCityOrTown" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressCityOrTown" order="33.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressStateOrProvince" xlink:type="locator" xlink:label="dei_EntityAddressStateOrProvince" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressStateOrProvince" order="34.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressPostalZipCode" xlink:type="locator" xlink:label="dei_EntityAddressPostalZipCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressPostalZipCode" order="35.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CityAreaCode" xlink:type="locator" xlink:label="dei_CityAreaCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_CityAreaCode" order="36.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_LocalPhoneNumber" xlink:type="locator" xlink:label="dei_LocalPhoneNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_LocalPhoneNumber" order="37.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_WrittenCommunications" xlink:type="locator" xlink:label="dei_WrittenCommunications" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_WrittenCommunications" order="38.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_SolicitingMaterial" xlink:type="locator" xlink:label="dei_SolicitingMaterial" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_SolicitingMaterial" order="39.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_PreCommencementTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementTenderOffer" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_PreCommencementTenderOffer" order="40.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_PreCommencementIssuerTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementIssuerTenderOffer" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_PreCommencementIssuerTenderOffer" order="41.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_Security12bTitle" xlink:type="locator" xlink:label="dei_Security12bTitle" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_Security12bTitle" order="42.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_TradingSymbol" xlink:type="locator" xlink:label="dei_TradingSymbol" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_TradingSymbol" order="43.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_SecurityExchangeName" xlink:type="locator" xlink:label="dei_SecurityExchangeName" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_SecurityExchangeName" order="44.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityEmergingGrowthCompany" xlink:type="locator" xlink:label="dei_EntityEmergingGrowthCompany" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityEmergingGrowthCompany" order="45.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>7
<FILENAME>d19897d8k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2019-01-31"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="urgn-20200903.xsd" xlink:type="simple"/>
    <context id="duration_2020-09-03_to_2020-09-03">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001668243</identifier>
        </entity>
        <period>
            <startDate>2020-09-03</startDate>
            <endDate>2020-09-03</endDate>
        </period>
    </context>
    <dei:AmendmentFlag contextRef="duration_2020-09-03_to_2020-09-03">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey
      contextRef="duration_2020-09-03_to_2020-09-03"
      id="Hidden_dei_EntityCentralIndexKey">0001668243</dei:EntityCentralIndexKey>
    <dei:DocumentType contextRef="duration_2020-09-03_to_2020-09-03">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="duration_2020-09-03_to_2020-09-03">2020-09-03</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="duration_2020-09-03_to_2020-09-03">UROGEN PHARMA LTD.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="duration_2020-09-03_to_2020-09-03">L3</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="duration_2020-09-03_to_2020-09-03">001-38079</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="duration_2020-09-03_to_2020-09-03">98-1460746</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="duration_2020-09-03_to_2020-09-03">400 Alexander Park Drive</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2 contextRef="duration_2020-09-03_to_2020-09-03">4th Floor</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown contextRef="duration_2020-09-03_to_2020-09-03">Princeton</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="duration_2020-09-03_to_2020-09-03">NJ</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="duration_2020-09-03_to_2020-09-03">08540</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="duration_2020-09-03_to_2020-09-03">+1 (646)</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="duration_2020-09-03_to_2020-09-03">768-9780</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="duration_2020-09-03_to_2020-09-03">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="duration_2020-09-03_to_2020-09-03">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="duration_2020-09-03_to_2020-09-03">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="duration_2020-09-03_to_2020-09-03">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle contextRef="duration_2020-09-03_to_2020-09-03">Ordinary Shares, par value NIS0.01 per share</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="duration_2020-09-03_to_2020-09-03">URGN</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="duration_2020-09-03_to_2020-09-03">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="duration_2020-09-03_to_2020-09-03">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>8
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140241060994488">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Document and Entity Information<br></strong></div></th>
<th class="th"><div>Sep. 03, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001668243<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Sep.  03,  2020<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">UROGEN PHARMA LTD.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation State Country Code</a></td>
<td class="text">L3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-38079<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">98-1460746<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">400 Alexander Park Drive<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">4th Floor<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Princeton<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">NJ<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">08540<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">+1 (646)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">768-9780<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre Commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre Commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Security 12b Title</a></td>
<td class="text">Ordinary Shares, par value NIS0.01 per share<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">URGN<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented.  If there is no historical data in the report, use the filing date. The format of the date is CCYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>9
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M/+Q^5_]23!XFLZ":C63RG<=F?=WJM4C,EC1/S%1NOK+]A K 2":Z^"2;7=_
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MJMWA>M<P,BL.M MIX'A<7*X9A:U@.\#]I93FO6'/R.5?'(-_ 5!+ P04
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MCMQC)8QQ8K3^-8+)#^Q^ %!+ P04    " !!0"E1'#AEZC\!   \ @  #P
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M=Y-[2:AU[D&P]_ :C1W-CQ^W_ %02P,$%     @ 04 I420>FZ*M    ^ $
M !H   !X;"]?<F5L<R]W;W)K8F]O:RYX;6PN<F5L<[61/0Z#, R%KQ+E #50
MJ4,%3%U8*RX0!?,C$A+%K@JW+X4!D#IT8;*>+7_OR4Z?:!1W;J"V\R1&:P;*
M9,OL[P"D6[2*+L[C,$]J%ZSB688&O-*]:A"2*+I!V#-DGNZ9HIP\_D-T==UI
M?#C]LCCP#S"\7>BI160I2A4:Y$S":+8VP5+BRTR6HJ@R&8HJEG!:(.+)(&UI
M5GVP3TZTYWD7-_=%KLWC":[?#'!X=/X!4$L#!!0    ( $% *5%ED'F2&0$
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M;W!S+V%P<"YX;6Q02P$"% ,4    " !!0"E1,9M9F>X    K @  $0
M        @ &O    9&]C4')O<',O8V]R92YX;6Q02P$"% ,4    " !!0"E1
MF5R<(Q &  "<)P  $P              @ ', 0  >&PO=&AE;64O=&AE;64Q
M+GAM;%!+ 0(4 Q0    ( $% *5$ OW<>700  .X0   8              "
M@0T(  !X;"]W;W)K<VAE971S+W-H965T,2YX;6Q02P$"% ,4    " !!0"E1
M@ZFE ]0!   R!@  #0              @ &@#   >&PO<W1Y;&5S+GAM;%!+
M 0(4 Q0    ( $% *5&7BKL<P    !,"   +              "  9\.  !?
M<F5L<R\N<F5L<U!+ 0(4 Q0    ( $% *5$<.&7J/P$  #P"   /
M      "  8@/  !X;"]W;W)K8F]O:RYX;6Q02P$"% ,4    " !!0"E1)!Z;
MHJT   #X 0  &@              @ 'T$   >&PO7W)E;',O=V]R:V)O;VLN
M>&UL+G)E;'-02P$"% ,4    " !!0"E199!YDAD!  #/ P  $P
M    @ '9$0  6T-O;G1E;G1?5'EP97-=+GAM;%!+!08     "0 ) #X"   C
%$P     !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.20.2</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>95</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="d19897d8k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>100000 - Document - Document and Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.urogen.com//20200903/taxonomy/role/DocumentDocumentAndEntityInformation</Role>
      <ShortName>Document and Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" original="d19897d8k.htm">d19897d8k.htm</File>
    <File>d19897dex101.htm</File>
    <File>d19897dex102.htm</File>
    <File>urgn-20200903.xsd</File>
    <File>urgn-20200903_lab.xml</File>
    <File>urgn-20200903_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy>http://xbrl.sec.gov/dei/2019-01-31</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>14
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "d19897d8k.htm": {
   "axisCustom": 0,
   "axisStandard": 0,
   "contextCount": 1,
   "dts": {
    "inline": {
     "local": [
      "d19897d8k.htm"
     ]
    },
    "labelLink": {
     "local": [
      "urgn-20200903_lab.xml"
     ],
     "remote": [
      "https://xbrl.sec.gov/dei/2019/dei-doc-2019-01-31.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "urgn-20200903_pre.xml"
     ]
    },
    "referenceLink": {
     "remote": [
      "https://xbrl.sec.gov/dei/2019/dei-ref-2019-01-31.xml"
     ]
    },
    "schema": {
     "local": [
      "urgn-20200903.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd",
      "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd",
      "http://xbrl.sec.gov/sic/2011/sic-2011-01-31.xsd",
      "https://xbrl.sec.gov/naics/2017/naics-2017-01-31.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/deprecated-2009-12-16.xsd"
     ]
    }
   },
   "elementCount": 24,
   "entityCount": 1,
   "hidden": {
    "http://xbrl.sec.gov/dei/2019-01-31": 2,
    "total": 2
   },
   "keyCustom": 0,
   "keyStandard": 95,
   "memberCustom": 0,
   "memberStandard": 0,
   "nsprefix": "urgn",
   "nsuri": "http://www.urogen.com/20200903",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d19897d8k.htm",
      "contextRef": "duration_2020-09-03_to_2020-09-03",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "100000 - Document - Document and Entity Information",
     "role": "http://www.urogen.com//20200903/taxonomy/role/DocumentDocumentAndEntityInformation",
     "shortName": "Document and Entity Information",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d19897d8k.htm",
      "contextRef": "duration_2020-09-03_to_2020-09-03",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 0,
   "tag": {
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.urogen.com//20200903/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code",
        "terseLabel": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.urogen.com//20200903/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]",
        "terseLabel": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "xbrltype": "stringItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented.  If there is no historical data in the report, use the filing date. The format of the date is CCYY-MM-DD.",
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.urogen.com//20200903/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "terseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.urogen.com//20200903/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.urogen.com//20200903/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine2": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Address Line 2 such as Street or Suite number",
        "label": "Entity Address, Address Line Two",
        "terseLabel": "Entity Address, Address Line Two"
       }
      }
     },
     "localname": "EntityAddressAddressLine2",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.urogen.com//20200903/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.urogen.com//20200903/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.urogen.com//20200903/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.urogen.com//20200903/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.urogen.com//20200903/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.urogen.com//20200903/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number",
        "terseLabel": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.urogen.com//20200903/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation State Country Code",
        "terseLabel": "Entity Incorporation State Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.urogen.com//20200903/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.urogen.com//20200903/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.urogen.com//20200903/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.urogen.com//20200903/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.",
        "label": "Pre Commencement Issuer Tender Offer",
        "terseLabel": "Pre Commencement Issuer Tender Offer"
       }
      }
     },
     "localname": "PreCommencementIssuerTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.urogen.com//20200903/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_PreCommencementTenderOffer": {
     "auth_ref": [
      "r3"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.",
        "label": "Pre Commencement Tender Offer",
        "terseLabel": "Pre Commencement Tender Offer"
       }
      }
     },
     "localname": "PreCommencementTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.urogen.com//20200903/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Security 12b Title",
        "terseLabel": "Security 12b Title"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.urogen.com//20200903/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.urogen.com//20200903/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_SolicitingMaterial": {
     "auth_ref": [
      "r4"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.",
        "label": "Soliciting Material",
        "terseLabel": "Soliciting Material"
       }
      }
     },
     "localname": "SolicitingMaterial",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.urogen.com//20200903/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.urogen.com//20200903/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "dei_WrittenCommunications": {
     "auth_ref": [
      "r6"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.",
        "label": "Written Communications",
        "terseLabel": "Written Communications"
       }
      }
     },
     "localname": "WrittenCommunications",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.urogen.com//20200903/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    }
   },
   "unitCount": 0
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b"
  },
  "r1": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r2": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r3": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r4": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14a",
   "Subsection": "12"
  },
  "r5": {
   "Name": "Regulation 12B",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r6": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "425"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>15
<FILENAME>0001193125-20-241611-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001193125-20-241611-xbrl.zip
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M%EE=6KUQ(.GA!^J@9]Y_M=C_9:ES.EPAEUB%+A5RN5"1&X,("P]"5!!A/Z"
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M,*R60<><X24"5H@(VL=*87]A@/><$6[S_1C^V6U^SR)09XCB!H$?:X/_<'!
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M(P2=Z&J*S[ZD:]HC@DOH%_XW4%]0X4_BX9![P<M[H-N\^X;IEJRLF OQ[=4
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ME^2\"^[WP8)V9OH+R &%*?4I#PK6*NF%PX5);J=Q@_4 SVOU7R<WE6UB2F7
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MF?DKUV[K8/_@G2ON6\U6?1Q-Z(_S+>X>'HAH*H2_ +$7S[Y4*19UEQS#03?
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ME[7G]4K#WY+(XGUC$+@S^&4<3;RC_P=02P,$%     @ 04 I44?1M0:J(@
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MO2K@-(&+,4/#(L?^P!L!5L'T1#XO>E"J5WX:C'60! ]B/ Z](5EFO>]<=#Z
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M/0F4GLIY4T+$RKN,SM1:<U0 UF.49?O@0$LQLC:ME@O#S?VF6F?IC+75-MU
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MXSNOC._JICWH.,-;5J=JCWN!;8!?NQ<?X>+[P=7EZ7\!4$L#!!0    ( $%
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M8)HQ<ON6'JB/6*&F-71O6B^C&;2?JL=1'';7*@Y70/HH[([RK';XH=:N2<[
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MI,BCO@&I[CQ]P+P'R<9=M'J]<MN_)$C$I8/&]@_"$ECC!/EBOS=68+=ON$+
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MR(0H.X(,&Z$G[1UMPW;.^+Y:47_0[3?;Z[RF[T&E!,.B0OOJ+*-L/U:V+\;
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M:@Y[&^J$?2?"C4ZSK?_Z YIZ*#0E@BK0Y7G0?YMP&?4_,9H2F,>?=3R5ZJ%
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M5F,7<#U9^R.7S+;CVMTN75T3L_4N;G?ZW=YL-=.&7G\!4$L#!!0    ( $%
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M(CY[J)87@K029*60G@\ZM&%X0&CKI;CC6FWI7P&3[:+I+T)1>_X'4$L#!!0
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M*<62OP!02P$"% ,4    " !!0"E1VO!T[*0:  !<DP  #0
M@ $     9#$Y.#DW9#AK+FAT;5!+ 0(4 Q0    ( $% *5%'T;4&JB(  ."<
M   0              "  <\:  !D,3DX.3=D97@Q,#$N:'1M4$L! A0#%
M  @ 04 I4>[ 09O7*@  FJP  !               ( !IST  &0Q.3@Y-V1E
M>#$P,BYH=&U02P$"% ,4    " !!0"E1K>\V_&$#   @#   $0
M    @ &L:   =7)G;BTR,#(P,#DP,RYX<V102P$"% ,4    " !!0"E17%\W
M^H$&  !)1P  %0              @ $\;   =7)G;BTR,#(P,#DP,U]L86(N
M>&UL4$L! A0#%     @ 04 I4?D7L*+$!   RRP  !4              ( !
M\'(  '5R9VXM,C R,# Y,#-?<')E+GAM;%!+!08     !@ & 'P!  #G=P
"   !

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
